Cohort Study of Pioglitazone and Bladder Cancer in Patients With Type II Diabetes

NCT01637935 · clinicaltrials.gov ↗

COMPLETED

Status

193099

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Bladder Cancer

Interventions

DRUG: Pioglitazone

Sponsor

Takeda

Collaborators

[object Object]
[object Object]